# Colorectal Cancer Screening Gets a New Option Beyond Colonoscopy
Major medical organizations have expanded colorectal cancer screening guidelines to include an alternative to traditional colonoscopy. The updated recommendations recognize new testing methods that offer people more choices for detecting cancer risk.
Colonoscopy has long served as the gold standard for colorectal screening, allowing doctors to examine the entire colon and remove polyps before they become cancerous. However, the procedure requires sedation, bowel preparation, and time away from work. These barriers prevent many people from getting screened at all.
The revised guidelines now include newer screening options. Stool-based tests like multitarget stool DNA tests (such as Cologuard) and fecal immunochemical tests (FIT) can detect blood and abnormal DNA in stool samples. These at-home tests eliminate the need for sedation and invasive procedures. People collect samples privately and mail them to labs, making screening more accessible.
Another emerging option involves CT colonography, sometimes called virtual colonoscopy. This imaging technique uses a CT scanner to create detailed pictures of the colon without inserting a scope. While it still requires bowel preparation, it avoids sedation for most patients.
The guidelines maintain that colonoscopy remains highly effective for both detecting and removing precancerous polyps in one visit. But they recognize that a screening test people actually complete beats a perfect test they skip.
Screening recommendations still advise adults to begin at age 45, with timing depending on risk factors and family history. People with average risk typically need screening every 10 years for colonoscopy, every three years for stool DNA tests, or every five years for CT colonography.
Getting screened matters. Colorectal cancer is highly preventable when caught early through polyp removal. Rates of advanced disease diagnoses have climbed